BLIS Technologies (NZSE:BLT) Change In Receivables : NZ$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Change In Receivables?

BLIS Technologies's change in receivables for the quarter that ended in Sep. 2024 was NZ$0.00 Mil. It means BLIS Technologies's Accounts Receivable stayed the same from Mar. 2024 to Sep. 2024 .

BLIS Technologies's change in receivables for the fiscal year that ended in Mar. 2024 was NZ$0.00 Mil. It means BLIS Technologies's Accounts Receivable stayed the same from Mar. 2023 to Mar. 2024 .

BLIS Technologies's Accounts Receivable for the quarter that ended in Sep. 2024 was NZ$1.04 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BLIS Technologies's Days Sales Outstanding for the six months ended in Sep. 2024 was 34.01.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BLIS Technologies's liquidation value for the six months ended in Sep. 2024 was NZ$8.54 Mil.

BLIS Technologies Change In Receivables Historical Data

The historical data trend for BLIS Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Change In Receivables Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

BLIS Technologies Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

BLIS Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.00 Mil.

BLIS Technologies (NZSE:BLT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BLIS Technologies's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.041	/	5.586	*	91
=	34.01

2. In Ben Graham's calculation of liquidation value, BLIS Technologies's accounts receivable are only considered to be worth 75% of book value:

BLIS Technologies's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	8.993	-	1.648	+	0.75 * 1.041	+	0.5 * 0.82
=	8.54

BLIS Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).